Literature DB >> 18820880

[Interdisciplinary management of thoracic wall tumors: indication, technique, and results of interscapulothoracic amputation].

A Koscielny1, A Hirner, M Kaminski.   

Abstract

Interscapulothoracic amputation of the upper extremity, described for the first time by Berger in 1887, has undergone a change of indication. Originally performed in traumatic injuries of the shoulder or arm, it has been done in radical resection of malignancies of the upper extremity, axilla, or the surrounding thoracic wall. Particularly it is performed in tumors which cannot be controlled by neoadjuvant therapies or locally by radiation. The indication, technique, and results of such amputation are discussed by presenting our patients operated on with the procedure. Although this treatment is combined with a loss of function and body integrity, it is safe and sufficiently radical. The loss of function and integrity may be compensated by prosthetic reconstitution.

Entities:  

Mesh:

Year:  2009        PMID: 18820880     DOI: 10.1007/s00104-008-1608-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  5 in total

1.  Interscapulothoracic amputation.

Authors:  M B Yoak; W M Cocke; J P Carey
Journal:  W V Med J       Date:  2001 May-Jun

2.  [The epaulette flap: replantation of osteomyocutaneous forearm segments in interscapulo-thoracic amputation].

Authors:  H U Steinau; G Germann; W Klein; C Josten
Journal:  Chirurg       Date:  1992-04       Impact factor: 0.955

3.  Technique of forequarter (interscapulothoracic) amputation.

Authors:  Toni Ferrario; Paul Palmer; Constantine P Karakousis
Journal:  Clin Orthop Relat Res       Date:  2004-06       Impact factor: 4.176

4.  Tikhoff-Linberg procedure for bone and soft tissue tumors of the shoulder girdle.

Authors:  G Voggenreiter; S Assenmacher; K P Schmit-Neuerburg
Journal:  Arch Surg       Date:  1999-03

5.  The interscapulothoracic amputation in the treatment of malignant diseases of the upper extremity with a review of the literature.

Authors:  S J Ham; H J Hoekstra; H Schraffordt Koops; W H Eisma; J Oldhoff
Journal:  Eur J Surg Oncol       Date:  1993-12       Impact factor: 4.424

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.